KLRK1 and neoplasm: (107) found that exogenous IL-15 safeguards NK from the inhibitory influence of tumor-microvesicles via modulating SMAD signaling and that IL-15 can avert microvesicle-induced down-regulation of NK group 2D (NKG2D) expression.